I understand that there could some legal/compliance issue to manage when it comes to communication what's going on with the FDA, but not saying anything at all just send a negative message to the market and even worse just says to the retail investors "we don't give a.... about you"
I thought that DellaPenna would have change at least a little beat this unprofessional behaviour